First-in-Human Trial of VBC101 in Participants With Advanced Solid Tumor Malignancies

Recruiting

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(5 sites)

United States

Start Midwest, Grand Rapids, Michigan

The University of Texas MD Anderson Cancer Center, Houston, Texas

NEXT Oncology, San Antonio, Texas

START Mountain Region, LLC., West Valley City, Utah

NEXT Virginia, Fairfax, Virginia